Recombinant activated factor VIIa (rFVIIa) in intractable haemorrhage: use of a clinical scoring system

scientific article published on 01 May 2006

Recombinant activated factor VIIa (rFVIIa) in intractable haemorrhage: use of a clinical scoring system is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1423-0410.2006.00768.X
P698PubMed publication ID16635077

P50authorRichard PughQ57019280
Richard WenstoneQ59160487
P2093author name stringN Goh
P2860cites workRecombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleedingQ35839531
Recombinant activated factor VII (rFVIIa/NovoSeven) in intractable haemorrhage: use of a clinical scoring system to predict outcome.Q50746970
Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case-control analysis.Q51240376
P433issue4
P304page(s)331; author reply 332
P577publication date2006-05-01
P1433published inVox SanguinisQ15708866
P1476titleRecombinant activated factor VIIa (rFVIIa) in intractable haemorrhage: use of a clinical scoring system
P478volume90

Search more.